Cargando…

Intracranial non-myxoid angiomatoid fibrous histiocytoma with EWSR1-CREB1 transcript fusion treated with doxorubicin: A case report

Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor that has only been reported in the central nervous system in case reports. After surgery, patients exhibit tumor recurrence. Pathological diagnosis of AHF remains difficult, especially in sites other than skin. AFH can harbor charact...

Descripción completa

Detalles Bibliográficos
Autores principales: Garnier, Louis, Fenouil, Tanguy, Pissaloux, Daniel, Ameli, Roxana, Ducray, François, Meyronet, David, Honnorat, Jerome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138849/
https://www.ncbi.nlm.nih.gov/pubmed/34055346
http://dx.doi.org/10.3892/mco.2021.2293
_version_ 1783695889574920192
author Garnier, Louis
Fenouil, Tanguy
Pissaloux, Daniel
Ameli, Roxana
Ducray, François
Meyronet, David
Honnorat, Jerome
author_facet Garnier, Louis
Fenouil, Tanguy
Pissaloux, Daniel
Ameli, Roxana
Ducray, François
Meyronet, David
Honnorat, Jerome
author_sort Garnier, Louis
collection PubMed
description Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor that has only been reported in the central nervous system in case reports. After surgery, patients exhibit tumor recurrence. Pathological diagnosis of AHF remains difficult, especially in sites other than skin. AFH can harbor characteristic translocations implying that the Ewing sarcoma breakpoint region 1 gene (EWSR1) fuses with the transcription factor cyclic AMP response element binding (CREB) family genes. Doxorubicin is a chemotherapy that has previously been used successfully in two metastatic soft tissue AFH cases but never in intracranial AFH. The present report describes a case of an adult with a progressive classical intracranial non-myxoid AFH with ESWR1-CREB1 transcript fusion 4 years after surgery. The patient was treated with doxorubicin as a single agent chemotherapy. This treatment resulted in a prolonged stable disease 15 months after treatment discontinuation. This is the first reported case of a treatment with doxorubicin in an adult with progressive intracranial AFH with ESWR1-CREB1 transcript fusion which was sustained after treatment discontinuation.
format Online
Article
Text
id pubmed-8138849
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-81388492021-05-27 Intracranial non-myxoid angiomatoid fibrous histiocytoma with EWSR1-CREB1 transcript fusion treated with doxorubicin: A case report Garnier, Louis Fenouil, Tanguy Pissaloux, Daniel Ameli, Roxana Ducray, François Meyronet, David Honnorat, Jerome Mol Clin Oncol Articles Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor that has only been reported in the central nervous system in case reports. After surgery, patients exhibit tumor recurrence. Pathological diagnosis of AHF remains difficult, especially in sites other than skin. AFH can harbor characteristic translocations implying that the Ewing sarcoma breakpoint region 1 gene (EWSR1) fuses with the transcription factor cyclic AMP response element binding (CREB) family genes. Doxorubicin is a chemotherapy that has previously been used successfully in two metastatic soft tissue AFH cases but never in intracranial AFH. The present report describes a case of an adult with a progressive classical intracranial non-myxoid AFH with ESWR1-CREB1 transcript fusion 4 years after surgery. The patient was treated with doxorubicin as a single agent chemotherapy. This treatment resulted in a prolonged stable disease 15 months after treatment discontinuation. This is the first reported case of a treatment with doxorubicin in an adult with progressive intracranial AFH with ESWR1-CREB1 transcript fusion which was sustained after treatment discontinuation. D.A. Spandidos 2021-07 2021-05-09 /pmc/articles/PMC8138849/ /pubmed/34055346 http://dx.doi.org/10.3892/mco.2021.2293 Text en Copyright: © Garnier et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Garnier, Louis
Fenouil, Tanguy
Pissaloux, Daniel
Ameli, Roxana
Ducray, François
Meyronet, David
Honnorat, Jerome
Intracranial non-myxoid angiomatoid fibrous histiocytoma with EWSR1-CREB1 transcript fusion treated with doxorubicin: A case report
title Intracranial non-myxoid angiomatoid fibrous histiocytoma with EWSR1-CREB1 transcript fusion treated with doxorubicin: A case report
title_full Intracranial non-myxoid angiomatoid fibrous histiocytoma with EWSR1-CREB1 transcript fusion treated with doxorubicin: A case report
title_fullStr Intracranial non-myxoid angiomatoid fibrous histiocytoma with EWSR1-CREB1 transcript fusion treated with doxorubicin: A case report
title_full_unstemmed Intracranial non-myxoid angiomatoid fibrous histiocytoma with EWSR1-CREB1 transcript fusion treated with doxorubicin: A case report
title_short Intracranial non-myxoid angiomatoid fibrous histiocytoma with EWSR1-CREB1 transcript fusion treated with doxorubicin: A case report
title_sort intracranial non-myxoid angiomatoid fibrous histiocytoma with ewsr1-creb1 transcript fusion treated with doxorubicin: a case report
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138849/
https://www.ncbi.nlm.nih.gov/pubmed/34055346
http://dx.doi.org/10.3892/mco.2021.2293
work_keys_str_mv AT garnierlouis intracranialnonmyxoidangiomatoidfibroushistiocytomawithewsr1creb1transcriptfusiontreatedwithdoxorubicinacasereport
AT fenouiltanguy intracranialnonmyxoidangiomatoidfibroushistiocytomawithewsr1creb1transcriptfusiontreatedwithdoxorubicinacasereport
AT pissalouxdaniel intracranialnonmyxoidangiomatoidfibroushistiocytomawithewsr1creb1transcriptfusiontreatedwithdoxorubicinacasereport
AT ameliroxana intracranialnonmyxoidangiomatoidfibroushistiocytomawithewsr1creb1transcriptfusiontreatedwithdoxorubicinacasereport
AT ducrayfrancois intracranialnonmyxoidangiomatoidfibroushistiocytomawithewsr1creb1transcriptfusiontreatedwithdoxorubicinacasereport
AT meyronetdavid intracranialnonmyxoidangiomatoidfibroushistiocytomawithewsr1creb1transcriptfusiontreatedwithdoxorubicinacasereport
AT honnoratjerome intracranialnonmyxoidangiomatoidfibroushistiocytomawithewsr1creb1transcriptfusiontreatedwithdoxorubicinacasereport